Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Dupont De Nemours Inc (DD)

  • Business News
  • June 11, 2025, 12:00 UTC
  • 0

DuPont Completes Qnity™ Board of Directors

Market reaction Comment Full text

vTv Therapeutics Inc. (VTVT)

  • Business News
  • June 11, 2025, 12:00 UTC
  • 0

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series

Market reaction Comment Full text

uniQure NV (QURE)

  • Business News
  • June 11, 2025, 12:00 UTC
  • 0

uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer

Market reaction Comment Full text

Tempest Therapeutics Inc. (TPST)

  • Business News
  • June 11, 2025, 12:00 UTC
  • 0

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock

Market reaction Comment Full text

Ocugen Inc. (OCGN)

  • Business News
  • June 11, 2025, 11:32 UTC
  • 1

Ocugen To Present at BIO International Convention 2025

Market reaction Comment Full text

BRAINSWAY (BWAY)

  • Business News
  • June 11, 2025, 11:30 UTC
  • 1

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Market reaction Comment Full text

Cybin Inc (CYBN)

  • Business News
  • June 11, 2025, 11:30 UTC
  • 1

Cybin - Cybin to Participate in the 2025 Psychedelic Science Conference

Market reaction Comment Full text

Brainsway Ltd (BWAY)

  • Business News
  • June 11, 2025, 11:30 UTC
  • 1

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Market reaction Comment Full text

Vaxart Inc (VXRT)

  • Business News
  • June 11, 2025, 11:30 UTC
  • 3

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

Market reaction Comment Full text

Cybin Inc (CYBN)

  • Business News
  • June 11, 2025, 11:30 UTC
  • 3

Cybin to Participate in the 2025 Psychedelic Science Conference

Market reaction Comment Full text
  • Previous
  • 76
  • 77
  • 78
  • 79
  • 80
  • Next

Search

News categories

  • Technical Exchange News(9364)
  • Event(407)
  • SEC News(152836)
  • FDA Approval(8737)
  • Company Report(721)
  • Business News(104392)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin